Early Doppler-Assisted Mobilization in Adults After Acute Ischemic Stroke
DOP-MOBILIZE
1 other identifier
interventional
1,300
1 country
3
Brief Summary
Post-stroke mobilization remains a subject of ongoing debate. While early mobilization-particularly the first out-of-bed mobilization-has been associated with reduced systemic complications and earlier rehabilitation, it also carries potential risks, such as neurological deterioration in the presence of hemodynamic instability. In this study, the primary aim is to investigate whether early mobilization, guided by hemodynamic evaluation after acute ischemic stroke offers superior outcomes compared to standard clinical care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2025
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 4, 2025
CompletedFirst Submitted
Initial submission to the registry
September 16, 2025
CompletedFirst Posted
Study publicly available on registry
November 18, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
January 29, 2026
January 1, 2026
1.5 years
September 16, 2025
January 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Functional status at 3 months after ischemic stroke
Functional status assessment at 3 months after ischemic stroke, using the modified Rankin Scale (mRS), analyzed on an ordinal scale (0-6), to measure the degree of dependence/functional impairment. Score ranges: 0-no residual symptoms (better outcome); 1. no significant disability; 2. slight disability; 3. moderate disability; 4. moderately severe disability; 5. severe disability; 6. death (worse outcome).
3 months post-stroke
Secondary Outcomes (18)
Neurological Assessment (NIHSS Scale)
Day 0, 48 hours, Day 7 and Month 3
Development of hospital-acquired infections
Up to 7 days
Vital signs - Body temperature
Day 0, 48 hours, Day 7
Vital signs - Systolic and diastolic blood pressure
Day 0, 48 hours, Day 7
Vital signs - Heart rate
Day 0, 48 hours, Day 7
- +13 more secondary outcomes
Study Arms (2)
Doppler-guided early mobilization
EXPERIMENTALPatients with ischemic stroke will be mobilized based on the results of carotid and transcranial Doppler ultrasound examinations. If significant hemodynamic alterations are identified, such as stenosis ≥70% or intracranial occlusions, mobilization will be gradually introduced up to the 5th-7th day post-event. In the absence of such alterations, mobilization will begin immediately, with out-of-bed transfer to a chair within 48 hours and gait training, if clinically feasible.
Standard Care Mobilization - Control Group
NO INTERVENTIONPatients with ischemic stroke are mobilized according to standard clinical practice, without considering hemodynamic assessment results from Doppler ultrasound. Mobilization is introduced gradually, guided by the patient's clinical tolerance.
Interventions
Individualized early mobilization after ischemic stroke, guided by hemodynamic assessment using carotid and transcranial Doppler ultrasound. The type and timing of mobilization are adjusted according to the presence of significant hemodynamic alterations.
Eligibility Criteria
You may qualify if:
- Patients diagnosed with ischemic stroke aged 18 years or older;
- Ability to undergo carotid and transcranial Doppler ultrasound, as well as to mobilize within 48 hours;
- Informed consent obtained from the patient or legal representative.
You may not qualify if:
- Pre-existing disability with a modified Rankin Scale (mRS) score ≥ 4;
- Diagnosis of Transient Ischemic Attack (TIA);
- Severe hemodynamic instability, defined as:
- Systolic blood pressure \< 100 mmHg or \> 220 mmHg;
- Peripheral oxygen saturation \< 92%;
- Heart rate \< 40 or \> 112 beats per minute;
- Body temperature \> 38.5°C;
- Neurological deterioration with altered level of consciousness (defined as Glasgow Coma Scale \< 10);
- Patients who underwent neurosurgical intervention within the past 30 days;
- Concomitant diagnosis of a rapidly progressive fatal disease (e.g., terminal-stage cancer);
- Requirement for continuous monitoring or continuous intravenous drug infusion;
- Acute deep vein thrombosis/pulmonary embolism.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Unidade Local de Saúde de Coimbra, EPElead
- Unidade Local de Saúde São Joãocollaborator
- Unidade Local de Saúde Santa Mariacollaborator
Study Sites (3)
Unidade Local de Saude de Coimbra
Coimbra, Coimbra District, 3004-561, Portugal
Unidade Local de Saúde de Santa Maria
Lisbon, Lisbon District, 1649-028, Portugal
Unidade Local de Saúde de São João
Porto, Porto District, 4200-319, Portugal
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joao Sargento Freitas, MD, PhD
Unidade Local de Saude de Coimbra
- STUDY DIRECTOR
Joao Sargento Freitas, MD, PhD
Unidade Local de Saude de Coimbra
Central Study Contacts
Clinical Trials Unit - Coimbra Academic Clinical Center CTU-CACC Unidade Local de Saude de Coimbra
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, MD, PhD, Stroke Unit Coordinator
Study Record Dates
First Submitted
September 16, 2025
First Posted
November 18, 2025
Study Start
June 4, 2025
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2027
Last Updated
January 29, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
Data will be irreversibly anonymized and exclusively handled by researchers involved in the study.